Artificial Intelligence in Urooncology: What We Have and What We Expect
Authors:
Open Access
Abstract
Introduction: Artificial intelligence is transforming healthcare by driving innovation, automation, and optimization across various fields of medicine. The aim of this study was to determine whether artificial intelligence (AI) techniques can be used in the diagnosis, treatment planning, and monitoring of urological cancers. Methodology: We conducted a thorough search for original and review articles published until 31 May 2022 in the PUBMED/Scopus database. Our search included several terms related to AI and urooncology. Articles were selected with the consensus of all authors. Results: Several types of AI can be used in the medical field. The most common forms of AI are machine learning (ML), deep learning (DL), neural networks (NNs), natural language processing (NLP) systems, and computer vision. AI can improve various domains related to the management of urologic cancers, such as imaging, grading, and nodal staging. AI can also help identify appropriate diagnoses, treatment options, and even biomarkers. In the majority of these instances, AI is as accurate as or sometimes even superior to medical doctors. Conclusions: AI techniques have the potential to revolutionize the diagnosis, treatment, and monitoring of urologic cancers. The use of AI in urooncology care is expected to increase in the future, leading to improved patient outcomes and better overall management of these tumors.Keywords
Funding Information
- Uniwersytet Medyczny im. Piastów Slaskich we Wroclawiu (SUBZ.C090.23.080)
This publication has 107 references indexed in Scilit:
- Renal cancerThe Lancet, 2016
- Deep learningNature, 2015
- Low biopsy volume in ureteroscopy does not affect tumor biopsy grading in upper tract urothelial carcinomaUrologic Oncology: Seminars and Original Investigations, 2013
- Outcome Assessment of Patients With Metastatic Renal Cell Carcinoma Under Systemic Therapy Using Artificial Neural NetworksClinical Genitourinary Cancer, 2012
- Prostate CancerThe Scientific World Journal, 2011
- Renal cancerCritical Reviews in Oncology/Hematology, 2007
- Application of Artificial Intelligence to the Management of Urological CancerJournal of Urology, 2007
- Artificial intelligence in medicineThe Annals of The Royal College of Surgeons of England, 2004
- Comparison of Cox Regression With Other Methods for Determining Prediction Models and NomogramsJournal of Urology, 2003
- Prognostic significance of morphologic parameters in renal cell carcinomaAmerican Journal of Surgical Pathology, 1982